BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the ...
Laboratory Corporation of America Holdings (LabCorp) is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS AmpliPrep/COBAS TaqMan HCV ...
Occult HCV infection is defined by the existence of an HCV-RNA-positive strand in the serum, lymphoid cells (peripheral blood mononuclear cells [PBMCs]) and/or the liver, and the detection of a ...
According to a new study presented at The Liver Meeting, combining universal screening for the hepatitis C virus (HCV) with reflex RNA PCR in pregnant women is more cost-effective than risk-based ...
July 26, 2005 — The European Commission has approved a cryoablation catheter system for the treatment of atrial fibrillation; an automated, real-time, polymerase chain reaction assay to monitor ...
Chronic hepatitis C infection affects an estimated 50 million people globally, causes approximately 242,000 deaths per year mostly due to cirrhosis and liver cancer Same-day results will help ...
Agreement Significantly Adds to the North American Test Menus of Both Parties and Aims to Increase the Adoption of HPV Screening GERMANTOWN, Maryland and DES PLAINES ...
To develop the new rapid polymerase chain reaction (PCR) test for HCV, the scientists used the DASH® (Diagnostic Analyzer for Specific Hybridization)PCR platform, which was originally developed at ...
The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results